Company Nextgen Biomed Ltd

Equities

NXGN

IL0010839301

Medical Equipment, Supplies & Distribution

Market Closed - TEL AVIV STOCK EXCHANGE 13:49:49 12/05/2024 BST 5-day change 1st Jan Change
101.8 ILa 0.00% Intraday chart for Nextgen Biomed Ltd 0.00% -19.97%

Business Summary

Nextgen Biomed Ltd is an Israel-based research and development company. Its main activity is to own EyePen product. The Company's product is dedicated to people with diabetes and consists of an injection module which allows to monitor the doses and time of insulin intake. The EyePen mobile app keeps diabetes management systematic by monitoring behavior and provides alerts for human errors such as forgetting a pen, double insulin injections, or skipping injections.

Number of employees: 15

Managers

Managers TitleAgeSince
Chief Executive Officer 48 19/11/22
Director of Finance/CFO 39 16/01/23
Comptroller/Controller/Auditor 69 07/08/00

Members of the board

Members of the board TitleAgeSince
Director/Board Member 49 11/06/22
Chairman 76 06/01/21
Director/Board Member 62 16/11/22
Comptroller/Controller/Auditor 69 07/08/00
Director/Board Member 35 05/12/22
Director/Board Member 43 17/12/22
Director/Board Member 74 16/11/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,431,276 6,861,089 ( 92.33 %) 0 92.33 %

Company contact information

Nextgen Biomed Ltd.

P. O. Box 4318

, Raanana

+

address Nextgen Biomed Ltd(NXGN)
  1. Stock Market
  2. Equities
  3. NXGN Stock
  4. Company Nextgen Biomed Ltd